Missing/wrong data?
Log in to edit
Open-label use of highly purified CBD (Epidiolex®) in patients with CDKL5 deficiency disorder and Aicardi, Dup15q, and Doose syndromes
article
Author/s
author: Orrin Devinsky, Chloe Verducci, Daniel Friedman, Jerzy P Szaflarski
Work details
Publication date
July 11, 2018
-
-
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.